Founder.page ↗
Clicks.page ↗Biocartesian
Connect pooled genetic perturbations to single-cell imaging phenotypes with ARADIA™ technology.
- Founded
- 2024
- Category
- SaaS
- Funding
- VC-backed
Every fact above is shown only where it could be checked against a source: funding against a primary source, backers against the investor’s own directory, and a location only where the company names that city on its own site. A row that is absent is one we could not source, not a zero. The summary is the company’s own current wording. Category is our own classification. Spotted something wrong? Tell us.
Investors backing Biocartesian
- Y Combinator
Frequently asked questions
What does Biocartesian do?
Connect pooled genetic perturbations to single-cell imaging phenotypes with ARADIA™ technology.
Where is Biocartesian based?
Location for Biocartesian has not been disclosed publicly.
When was Biocartesian founded?
Biocartesian was founded in 2024.
How much has Biocartesian raised?
Biocartesian is vc-backed. Funding details have not been disclosed.
Who has invested in Biocartesian?
Biocartesian is backed by Y Combinator.